Filgrastim Recruiting Phase N/A Trials for Malignancies, Hematologic Treatment

IndicationsStatusPurposePhase
RecruitingTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02880293Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor